HDL-targeted therapies: progress, failures and future

Kingwell, Bronwyn A., Chapman, M. John, Kontush, Anatol, Miller, Norman E.·2014·Nature Reviews Drug Discovery
DOI 10.1038/nrd4279

Cites (228)

Items 201–226 of 226

  1. An apoA-I mimetic peptide increases LCAT activity in mice through increasing HDL concentration
    Xun Chen, Charlotte A. Burton, Xuelei Sherry Song, Lesley Ann McNamara, Annunziata Langella, Simona Cianetti, Ching H. Chang, Jun Wang · 2009 · International Journal of Biological Sciences
  2. High-Density Lipoprotein Particle Number
    Emil M. deGoma, Daniel James Rader · 2012 · Journal of the American College of Cardiology
  3. Targeting High Density Lipoproteins in the Prevention of Cardiovascular Disease?
    Daniel B. Larach, Emil M. deGoma, Daniel James Rader · 2012 · Current Cardiology Reports
  4. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: A nested case–control study
    Paul J.W.H. Kappelle, Frank G. Perton, Hans L. Hillege, Geesje M. Dallinga‐Thie, Robin P. F. Dullaart · 2011 · Atherosclerosis
  5. Cholesteryl ester transfer protein in patients with coronary heart disease
    Kristina Duwensee, Lutz Philipp Breitling, Ivan Tancevski, Dietrich Rothenbacher, Egon Demetz, Josef R. Patsch, Andreas Ritsch, Kathrin Eller, Hermann Brenner · 2010 · European Journal of Clinical Investigation
  6. The Effect of Apolipoprotein Mimetic Peptides in Inflammatory Disorders Other Than Atherosclerosis
    Mohamad Navab, Gattadahalli M. Anantharamaiah, Alan M. Fogelman · 2008 · Trends in Cardiovascular Medicine
  7. An apoA-I mimetic peptide facilitates off-loading cholesterol from HDL to liver cells through scavenger receptor BI
    Xuelei Sherry Song, Paul A. Fischer, Xun Chen, Charlotte A. Burton, Jun Wang · 2009 · International Journal of Biological Sciences
  8. Lipoprotein remodeling generates lipid-poor apolipoprotein A-I particles in human interstitial fluid
    N.E. Miller, Waldemar Lech Olszewski, Hiroaki Hattori, Irina P. Miller, Takeshi Kujiraoka, Oka T, Tadao Iwasaki, M. Nazeem Nanjee · 2012 · American Journal of Physiology-Endocrinology and Metabolism
  9. ApoA-I mimetic peptides promote pre-β HDL formation in vivo causing remodeling of HDL and triglyceride accumulation at higher dose
    Ester Carballo‐Jane, Zhu Chen, Edward A. O’Neill, Jun Wang, Charlotte A. Burton, Ching-Hsin Chang, Xun Chen, Suzanne S. Eveland, Betsy Frantz, Karen Gagen et al. · 2010 · Bioorganic & Medicinal Chemistry
  10. Reference intervals for plasma apolipoprotein A-1 determined with a standardized commercial immunoturbidimetric assay: results from the Framingham Offspring Study
    John H. Contois, J R McNamara, C Lammi-Keefe, P W Wilson, Tatyana Massov, Ernst J. Schaefer · 1996 · Clinical Chemistry
  11. Very High Density Lipoproteins Induced by Plasma Cholesteryl Ester Transfer Protein (CETP) Have a Potent Antiatherogenic Functiona
    SHIZUYA YAMASHITA, Masato Ishigami, TAKESHI ARAI, Naohiko Sakai, Ken‐ichi Hirano, Kaoru Kameda-Takemura, Katsuto Tokunaga, Yūji Matsuzawa · 1994 · Annals of the New York Academy of Sciences
  12. Importance of macrophage cholesterol content on the flux of cholesterol mass
    Sandhya Sankaranarayanan, Margarita de la Llera-Moya, Denise Drazul‐Schrader, Bela F. Asztalos, Ginny L. Weibel, George H. Rothblat · 2010 · Journal of Lipid Research
  13. Association of Coronary Heart Disease with Pre-β-HDL Concentrations in Japanese Men
    Hiroaki Hattori, Takeshi Kujiraoka, Tohru Egashira, Eiji Saito, Takayuki FUJIOKA, Sadao Takahashi, Mayumi Ito, Jackie A. Cooper, Irina P. Stepanova, M. Nazeem Nanjee et al. · 2004 · Clinical Chemistry
  14. Design and synthesis of boronic acid inhibitors of endothelial lipase
    Daniel P. O’Connell, Daniel F. LeBlanc, Debra A. Cromley, Jeffrey T. Billheimer, Daniel James Rader, William W. Bachovchin · 2011 · Bioorganic & Medicinal Chemistry Letters
  15. Insight Into ABCG1-Mediated Cholesterol Efflux
    Jonathan D. Smith · 2006 · Arteriosclerosis Thrombosis and Vascular Biology
  16. Will Cholesteryl Ester Transfer Protein Inhibition Succeed Primarily by Lowering Low-Density Lipoprotein Cholesterol?
    Sekar Kathiresan · 2012 · Journal of the American College of Cardiology
  17. The difficult search for a ‘partner’ of statins in lipid-targeted prevention of vascular events: the re-emergence and fall of niacin
    Ulf Landmesser · 2013 · European Heart Journal
  18. Antisense oligonucleotide inhibition of cholesteryl ester transfer protein enhances RCT in hyperlipidemic, CETP transgenic, LDLr-/- mice
    Thomas A. Bell, Mark J. Graham, Richard G. Lee, Adam E. Mullick, Wuxia Fu, Dan Norris, Rosanne M. Crooke · 2013 · Journal of Lipid Research
  19. The ability of plasma to stimulate fibroblast cholesterol efflux is associated with the −629C→A cholesteryl ester transfer protein promoter polymorphism: Role of lecithin:cholesterol acyltransferase activity
    Susanna E. Borggreve · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  20. Recombinant High-Density Lipoprotein Formulations
    Esad Vucic, Robert S. Rosenson · 2010 · Current Atherosclerosis Reports
  21. Genetic polymorphisms of hepatic lipase and cholesteryl ester transfer protein, intermediate phenotypes, and coronary risk
    Jeffrey L. Anderson, John F. Carlquist · 2003 · Journal of the American College of Cardiology
  22. Systematic Review of CETP Inhibitors for Increasing High-Density Lipoprotein Cholesterol
    Bryan M. Bishop · 2013 · American Journal of Therapeutics
  23. The interrelationship between cerebral and coronary atherosclerosis; a preliminary report.
    Gofman Jw, N. Malamud, A SIMON, Waters Es, Wei Young · 1956 · PubMed
  24. Interpreting noncoding genetic variation in complex traits and human disease
    Ward, Lucas D, Kellis, Manolis · 2012 · Nature Biotechnology
  25. CSL112, a novel formulation of human apolipoprotein A-I, dramatically increases cholesterol efflux capacity in healthy subjects: a placebo-controlled, double-blinded, randomized, single ascending dose study
    Andreas Gille, Rachael Easton, Samuel D. Wright, Charles L. Shear · 2012 · F1000Research
  26. Abstract 11892: Safety and Pharmacokinetics of a Novel Formulation of Human Apolipoprotein A-I (CSL112) in Healthy Subjects: Results of a Placebo-Controlled, Randomized Multiple Ascending Dose Study
    Rachael Easton, Louise Tremper, Charles L. Shear · 2012 · Circulation